Ads
related to: pros and cons of humira
Search results
Results From The WOW.Com Content Network
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
The U.S. market share for Humira biosimilars stands at nearly 20%, compared with 2.2% in the first quarter of this year, Barclays analysts said in a note on Monday.
Humira was once the world's biggest selling prescription medicine with peak sales of $21.2 billion in 2022. Express Scripts and UnitedHealth Group's Optum Rx - two of the largest PBMs - chose to ...
AbbVie , which was spun out of health care stalwart Abbott Laboratories at the start of 2013, has beaten the market -- and its former parent company -- by leaps and bounds this year. It reported ...
Humira cost the U.S. government more than $2.9 billion in 2021, according to data from the agency that runs the Medicare and Medicaid health programs. It is expected to be excluded from government ...
CVS Health said on Wednesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of April 1, and will recommend ...
Ads
related to: pros and cons of humira